PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.55%
Revenue growth similar to OR's 9.92%. Walter Schloss would see if both companies share industry tailwinds.
42.29%
Gross profit growth above 1.5x OR's 10.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
31.40%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
31.40%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
19.33%
Net income growth at 50-75% of OR's 26.20%. Martin Whitman would question fundamental disadvantages in expenses or demand.
-73.33%
Negative EPS growth while OR is at 21.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-69.23%
Negative diluted EPS growth while OR is at 21.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.16%
Share reduction more than 1.5x OR's 0.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.51%
Reduced diluted shares while OR is at 0.35%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
16.30%
OCF growth 1.25-1.5x OR's 11.49%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
17.36%
Positive FCF growth while OR is negative. John Neff would see a strong competitive edge in net cash generation.
78.28%
10Y revenue/share CAGR under 50% of OR's 191.83%. Michael Burry would suspect a lasting competitive disadvantage.
140.24%
5Y revenue/share CAGR above 1.5x OR's 29.95%. David Dodd would look for consistent product or market expansions fueling outperformance.
48.10%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
252.65%
5Y OCF/share CAGR 1.25-1.5x OR's 192.29%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
55.50%
3Y OCF/share CAGR under 50% of OR's 22738.42%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
285.93%
5Y net income/share CAGR above 1.5x OR's 117.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
50.62%
3Y net income/share CAGR 50-75% of OR's 86.14%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
440.98%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
60.50%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.50%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
4.08%
Similar asset growth to OR's 3.85%. Walter Schloss finds parallel expansions or investment rates.
3.83%
50-75% of OR's 5.86%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-75.82%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-14.97%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.